Compare ARE & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARE | BRKR |
|---|---|---|
| Founded | 1994 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 6.7B |
| IPO Year | 1997 | 2000 |
| Metric | ARE | BRKR |
|---|---|---|
| Price | $50.37 | $58.49 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $56.22 | $48.54 |
| AVG Volume (30 Days) | 1.7M | ★ 2.1M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 11.40% | 0.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | 0.02 |
| Revenue | ★ $3,026,556,000.00 | $1,895,600,000.00 |
| Revenue This Year | N/A | $6.30 |
| Revenue Next Year | $0.15 | $3.81 |
| P/E Ratio | ★ $23.83 | $2,706.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $39.41 | $28.53 |
| 52 Week High | $88.24 | $56.22 |
| Indicator | ARE | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 63.79 | 85.11 |
| Support Level | $49.38 | $46.84 |
| Resistance Level | $54.86 | N/A |
| Average True Range (ATR) | 1.50 | 2.19 |
| MACD | 0.54 | 1.32 |
| Stochastic Oscillator | 87.96 | 99.18 |
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.